We are live on
!
Find out more
FCM
FourWorld Capital Management Portfolio holdings
AUM
$110M
1-Year Est. Return
44.07%
This Fund
S&P 500
This Quarter
Est. Return
-35.65%
1 Year Est. Return
+44.07%
3 Year Est. Return
+132.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$123M
AUM Growth
+$60M
(+95%)
Cap. Flow
+$75.3M
Cap. Flow
% of AUM
61.05%
Top 10 Holdings %
Top 10 Hldgs %
89.19%
Holding
31
New
7
Increased
7
Reduced
3
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sable Offshore Corp
SOC
|
+$76.5M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$4.45M |
| 3 |
Priority Technology Holdings
PRTH
|
+$2.28M |
| 4 |
WW
WW International
WW
|
+$873K |
| 5 |
Neuronetics
STIM
|
+$760K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arbutus Biopharma
ABUS
|
+$4.63M |
| 2 |
Evolv Technologies
EVLV
|
+$1.62M |
| 3 |
ZK
Zeekr
ZK
|
+$1.52M |
| 4 |
Darling Ingredients
DAR
|
+$1.05M |
| 5 |
Kaspi.kz JSC
KSPI
|
+$817K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 59.29% |
| 2 | Miscellaneous | 17.17% |
| 3 | Healthcare | 11.11% |
| 4 | Industrials | 4.82% |
| 5 | Technology | 3.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Sable Offshore Corp
SOC
$946M
| $73.1M | 59.29% |
+8,105,608
| New | +$76.5M |
|
2
PUT
iShares Russell 2000 ETF
IWM
$76.8B
| $6.15M | 4.99% |
25,000
+10,000
| +67% | +$2.46M |
|
3
Bristol-Myers Squibb
BMY
$130B
| $5.39M | 4.37% |
100,000
| – | – |
|
|
4
Evolv Technologies
EVLV
$924M
| $5.13M | 4.16% |
716,792
-228,110
| -24% | -$1.62M |
|
|
5
State Street Energy Select Sector SPDR ETF
XLE
$43.3B
| $4.47M | 3.63% |
+100,000
| New | +$4.45M |
|
6
PUT
Invesco QQQ Trust
QQQ
$474B
| $4.3M | 3.49% |
+7,000
| New | +$4.3M |
|
|
SRG
7
Seritage Growth Properties
SRG
$112M
| $3.62M | 2.93% |
1,113,243
| – | – |
|
8
CALL
ExxonMobil
XOM
$696B
| $3.01M | 2.44% |
+25,000
| New | +$2.9M |
|
|
9
CALL
Sable Offshore Corp
SOC
$946M
| $2.76M | 2.24% |
+306,500
| New | +$2.89M |
|
10
Solid Power
SLDP
$557M
| $2.03M | 1.64% |
477,129
| – | – |
|
|
11
Priority Technology Holdings
PRTH
$497M
| $2.01M | 1.63% |
+368,321
| New | +$2.28M |
|
|
WW
12
WW International
WW
$157M
| $1.76M | 1.43% |
60,375
+31,225
| +107% | +$873K |
|
13
Exagen
XGN
$185M
| $1.66M | 1.35% |
273,000
+46,000
| +20% | +$419K |
|
|
STLN
14
Starling Oncology
STLN
$657M
| $1.36M | 1.1% |
382,700
+24,700
| +7% | +$91.6K |
|
|
15
Neuronetics
STIM
$211M
| $1.29M | 1.04% |
931,250
+363,250
| +64% | +$760K |
|
16
CVRx
CVRX
$78.3M
| $1.28M | 1.04% |
180,000
+35,000
| +24% | +$319K |
|
17
TaskUs
TASK
$763M
| $1.18M | 0.96% |
100,000
| – | – |
|
18
AirSculpt Technologies
AIRS
$164M
| $951K | 0.77% |
480,274
+89,118
| +23% | +$541K |
|
19
Energy Services of America
ESOA
$208M
| $654K | 0.53% |
80,000
-32,357
| -29% | -$311K |
|
20
Magnachip Semiconductor
MX
$102M
| $551K | 0.45% |
+216,108
| New | +$602K |
|
21
Tevogen Inc Warrant
TVGNW
$978K
| $480K | 0.39% |
1,450,000
| – | – |
|
22
Cadiz
CDZI
$305M
| $158K | 0.13% |
28,184
-3,859
| -12% | -$20.7K |
|
|
23
Arbutus Biopharma
ABUS
$998M
| – | – |
-1,020,910
| Closed | -$4.63M |
|
|
24
CALL
AirSculpt Technologies
AIRS
$164M
| – | – |
-140,000
| Closed | -$1.12M |
|
25
Black Stone Minerals
BSM
$3.21B
| – | – |
-49,714
| Closed | -$653K |
|
Similar funds
DI
TF
SPM
FAOAI
CIM
ANBOT
QFMHK
BWM
FourWorld Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, FourWorld Capital Management held 31 positions worth $123M, up 95% from $63.3M the previous quarter. Its ten largest holdings account for 89% of the portfolio.
FourWorld Capital Management deployed $75.3M of net new capital in Q4 2025, opening 7 new positions and adding to 7 existing holdings. Its largest new stake was Sable Offshore Corp: 8,105,608 shares worth $73.1M.
By sector, the portfolio is most concentrated in Energy at 59% of assets, up from 1.8% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Evolv Technologies, an estimated $1.62M trimmed.
- FourWorld Capital Management's largest Q4 2025 buy was Sable Offshore Corp: 8,105,608 shares worth $73.1M.
- FourWorld Capital Management added most to WW International in Q4 2025, an estimated $873K increase.
- FourWorld Capital Management's biggest Q4 2025 reduction was Evolv Technologies, cutting an estimated $1.62M.
- FourWorld Capital Management fully exited Arbutus Biopharma in Q4 2025, selling an estimated $4.63M.
- FourWorld Capital Management's ten largest holdings make up 89% of its $123M portfolio in Q4 2025.
- FourWorld Capital Management opened 7 new positions and closed 9 in Q4 2025.
- FourWorld Capital Management's portfolio value rose 95% quarter-over-quarter to $123M.
Based on FourWorld Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.